I listened to the load up on GTLL before and lost a lot of money, please go to their page
Washington D.C., Aug. 5, 2014 — The Securities and Exchange Commission today charged four promoters with ties to the Pacific Northwest for manipulating the securities of several microcap companies, including marijuana-related stocks that the agency has warned investors about in recent weeks.
The SEC alleges that the four promoters bought inexpensive shares of thinly traded penny stock companies on the open market and conducted pre-arranged, manipulative matched orders and wash trades to create the illusion of an active market in these stocks. They then sold their shares in coordination with aggressive promotional campaigns that urged investors to buy the stocks because the prices were on the verge of rising substantially. However, these companies had little to no business operations at the time. The promoters reaped more than $2.5 million in illegal profits through their schemes.
Two of the companies manipulated in this case – GrowLife Inc. and Hemp Inc. – claim to be related to the #$%$ industry. The SEC has issued an investor alert warning about possible scams involving marijuana-related investments, noting that fraudsters often exploit the latest growth industries to lure investors into stock manipulation schemes. Other schemes by these four promoters involved an oil-and-gas company – Riverdale Oil and Gas Corporation – and three other microcap stocks, ISM International, Allied Products Corp, and Aden Solutions.
I've been here for a year and half, I have seen the ups and downs. I do believe in this company.
SUNNYVALE, Calif.-- Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a
biotechnology company discovering and developing treatments and diagnostics for
diseases associated with the neurodegeneration and apoptosis, today announced it has
appointed Russell Miller as Director of Investor Relations.
Mr. Miller previously served as Director of Investor Relations for US Data Works and for
Force Protection, Inc. He has assisted in raising capital for companies both public and
private, including real estate financing, development, and joint ventures for over 20 years.
He has successfully participated in private placements, mezzanine financing, joint
ventures, mergers and acquisitions, reverse mergers, national exchange up-listings and
acquisitions for companies on the OTC, AMEX, and NASDAQ. As a consultant Mr. Miller
has assisted a multitude of companies by developing their strategic plans for growth,
liquidity, and return on equity by facilitating relationships with investment bankers,
government relations officers, financiers, the media, and marketing and public relation
firms. He has a broad range of worldwide contacts throughout the investment banking
community, which include a large number of accredited investors and investment
On April 15, 2013, Amarantus Bioscience Holdings, Inc. appointed Russell Miller as Director of Investor Relations. Mr. Miller previously served as Director of Investor Relations for US Data Works and for Force Protection, Inc.